𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer

✍ Scribed by Robert E. Reiter; Issei Sato; George Thomas; Junqi Qian; Zhennan Gu; Tetsuro Watabe; Massimo Loda; Robert B. Jenkins


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
430 KB
Volume
27
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Gain of sequences on chromosome arm 8q is a common feature of prostate cancer that may correlate with metastatic and androgen-independent progression. The target gene(s) for this gain is not known, although MYC is amplified in a subset of advanced tumors and is one potential candidate. Prostate stem cell antigen (PSCA) is a prostate-specific cell surface protein that maps to chromosome region 8q24.2 and is overexpressed in prostate cancer. Our aim in this study was to test the hypothesis that PSCA overexpression may result from overrepresentation of chromosome arm 8q. Twenty locally advanced prostate cancers were analyzed by dual-probe fluorescence in situ hybridization (FISH) for alterations of MYC and PSCA. Extra copies of MYC were found in 12/20 (60%) tumors, including 5 (25%) with simple gain (no increase in MYC copy number relative to the chromosome 8 centromere) and 7 (35%) with an additional increase (AI or overrepresentation) in MYC copy number relative to the centromere. In the five cases with simple gain of MYC, there was a concomitant gain of PSCA. PSCA was overrepresented in 5/7 (71%) cases with AI of MYC. Immunohistochemical staining of the 20 tumors with monoclonal antibodies specific for PSCA showed a high degree of correlation between PSCA gene overrepresentation and protein overexpression. Four of 5 tumors with AI of PSCA overexpressed PSCA protein, compared with only 2/15 tumors with a normal PSCA copy number or simple gain of PSCA (P Ο­ 0.014). These results demonstrate that PSCA is co-overrepresented with MYC in a majority of cases, but may not be a necessary part of the 8q amplicon. PSCA protein overexpression can result from AI of PSCA and might be useful as a cell surface marker on prostate cancer cells with 8q overrepresentation.


πŸ“œ SIMILAR VOLUMES


Obesity and mortality in men with locall
✍ Jason A. Efstathiou; Kyounghwa Bae; William U. Shipley; Gerald E. Hanks; Miljenk πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract ## BACKGROUND. Greater body mass index (BMI) is associated with shorter time to prostate‐specific antigen (PSA) failure following radical prostatectomy and radiation therapy (RT). Whether BMI is associated with prostate cancer‐specific mortality (PCSM) was investigated in a large rando

Locally advanced prostate cancer: Bioche
✍ Bernardo Rocco; Epifanio Scardino; Ottavio de Cobelli πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 40 KB πŸ‘ 1 views

I n the article by Bruchovsky et al., 1 intermittent androgen sup- pression was evaluated in patients with clinically locally advanced prostate cancer who developed biochemical disease recurrence after radiotherapy. We consider it to be of utmost important to improve currently existing knowledge re